Randomised Ischaemic Mitral Evaluation (RIME) Trial (RIME)
Randomized Evaluation of Mitral Annuloplasty During Coronary Artery Bypass Grafting for Moderate Functional Ischaemic Mitral Regurgitation.
Sponsor: Blackpool Victoria Hospital
A EARLY_PHASE1 clinical study on Coronary Artery Disease and Mitral Regurgitation, this trial is completed. The trial is conducted by Blackpool Victoria Hospital and has accumulated 7 data snapshots since 2007. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed EARLY_PHASE1
-
Apr 2023 — Jul 2024 [monthly]
Completed EARLY_PHASE1
Phase: PHASE3 → EARLY_PHASE1
-
Oct 2021 — Apr 2023 [monthly]
Completed PHASE3
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jan 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Blackpool Victoria Hospital
- British Heart Foundation
- British Medical Association
- Department of Health, United Kingdom
- Imperial College Healthcare NHS Trust
- Imperial College London
- Medical University of Silesia
- Royal Brompton & Harefield NHS Foundation Trust
- University Hospitals Bristol and Weston NHS Foundation Trust
- University Hospitals, Leicester
For direct contact, visit the study record on ClinicalTrials.gov .